Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131808) titled 'Building an Artificial Intelligence Model for Prostate Cancer Prediction Based on Multimodal Data' on Sept. 7.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Prostate carcinoma
Intervention:
Gold Standard:Biopsy pathology
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-08-01
Target Sample Size: Target condition:100;Difficult condition:100
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=286043
Published by HT Digital Content Servi...